Balloon sinus dilation for chronic sinusitis

Series
ENT endoscopic procedures
Status
Published
Date
Number of report
053

Ask the expert

(we accept only company emails)

The report presents a summary of reimbursement situation for balloon sinus dilation for chronic sinusitis.

Indications include chronic maxillary, frontal and sphenoidal sinusitis.  

The only reimbursement within public / statutory health insurance systems is considered.

Report includes essential information about reimbursement and national funding, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland

It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Manufacturers of devices for balloon sinus dilation include:

  • Acclarent Inc (Relieva Spinplus, Relieva Scout)
  • Creganna Medical
  • DALENT Medical (Dalent Medical Sinusleeve)
  • Entellus Medical Inc. (Xpress ENT)
  • InnAccel
  • Jilin Coronado Medical Ltd (PTCA)
  • Medtronic (NuVent EM)
  • Meril Life Sciences Pvt (Mesire, Mozec)
  • Smith & Nephew plc (Ventera)

Table of content is not available at the moment. Report is still ongoing.

11

Oct 2019

MTRC has developed three reports on the key market access topics, including innovation funding, health technology assessment and funding frameworks for medical devices. These reports help to understand the relevance of these frameworks to certain types of medical technologies, including ENT technologies. This post provides some key facts about the HTA, funding and innovation payment landscape for ENT devices in Europe.

Read more

09

Sep 2019

NICE issued a consultation document about safety and efficacy of balloon cryoablation for Barrett’s oesophagus and squamous dysplasia of the oesophagus and balloon dilation for eustachian tube dysfunction which were considered for Interventional Procedures Guidance in development for public consultation until 20 September 2019.

Read more

22

Jul 2019

The reimbursement for the partial surgical removal of enlarged palatal tonsils has now been confirmed. Thus, contract physicians can bill this service from July 1, 2019. A decision to amend the EBM has been taken by the Valuation Committee.

Read more

17

Apr 2019

The report presents a summary of reimbursement situation for balloon sinus dilation for chronic sinusitis. Indications include chronic maxillary, frontal and sphenoidal sinusitis. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.

Read more

18

Oct 2018

The report presents a summary of reimbursement situation for cochlear implants for hearing loss. The only reimbursement within public / statutory health insurance systems is considered. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.

Read more
(we accept only company emails)